CARVEBLOC

This brand name is authorized in Nigeria.

Active ingredients

The drug CARVEBLOC contains one active pharmaceutical ingredient (API):

1	Carvedilol UNII 0K47UL67F2 - CARVEDILOL
	Carvedilol is a vasodilatory non-selective beta-blocker, which reduces the peripheral vascular resistance by selective alpha1-receptor blockade and suppresses the renin-angiotensin system through non-selective beta-blockade. Plasma renin activity is reduced and fluid retention is rare.
	Read more about Carvedilol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100636	Tablet	Carvebloc - 3.125 Tablets (smpc format) TAB 3.125 mg 2 x 14's (in Alu-Alu packs)	Film Coated Tablet 27 NF-PP-387181 CARVEBLOC - 3.125 TABLETS. CARVEDILOL TABLETS 3.125MG CARVEDILOL 3.125, ( MICROCRYSTALLINE CELLULOSE PH-102, LACTOSE DC, COLLOIIDAL SILICON DIOXIDE, SODIUM STARCH GLYCOLATE,CROSS POVIDONE,SODIUM LAURYL SULPHATE, MAGNESIUM STEARATE, HYDROXY PROPYL METHYL CELLULOSE E-15, POLYETHYLENE GLYCOL 6000, TITANIUM DIOXIDE, PURIFIED TALE, QUINOLINE YELLOW LAKE, ISOPROPYLENE DICHLORIDE ETC. ) A4-100636 Drugs Imported Products 2X14 Prescription Only Medicine (POM) 11/15/2023 TAMAR & PHAREZ NIG LTD, NYERE STREET, NARAYI H/COST KADUNA KADUNA SOUTH KADUNA 8030524857 tamphar@gmail.com Maxtar Bio-genics, Khasra No.705, Village Malku Majra, Nalagarh Road Baddi Teh. Nalagarh, Pradesh, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AG02	Carvedilol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AG Alpha and beta blocking agents
Discover more medicines within C07AG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100636